Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

Lancet
Thomas PilgrimStephan Windecker

Abstract

Drug-eluting stents combining an ultrathin cobalt-chromium stent platform with a biodegradable polymer eluting sirolimus have been shown to be non-inferior or superior to thin-strut, durable-polymer, everolimus-eluting stents in terms of 1 year safety and efficacy outcomes. In the randomised, single-blind, multicentre, non-inferiority BIOSCIENCE trial, we compared biodegradable-polymer sirolimus-eluting stents with durable-polymer everolimus-eluting stents in patients with chronic stable coronary artery disease or acute coronary syndromes. Here, we assess the final 5-year clinical outcomes of BIOSCIENCE with regards to the primary clinical outcome of target lesion failure, which was a composite of cardiac death, target vessel myocardial infarction, and clinically indicated target lesion revascularisation. The primary analysis was done by intention to treat. The BIOSCIENCE trial is registered with ClinicalTrials.gov, number NCT01443104. 2008 (95%) of 2119 patients recruited between March 1, 2012, and May 31, 2013, completed 5 years of follow-up. Target lesion failure occurred in 198 patients (cumulative incidence 20·2%) treated with biodegradable-polymer sirolimus-eluting stents and in 189 patients (18·8%) treated with durable-p...Continue Reading

Citations

Nov 20, 2018·European Heart Journal. Quality of Care & Clinical Outcomes·Giulio Guagliumi, Davide Capodanno
Jan 3, 2019·European Heart Journal·Dariusz DudekWilliam Wijns
Dec 21, 2018·Circulation. Cardiovascular Interventions·Charles D Resor, Deepak L Bhatt
Mar 6, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Hidenori KomiyamaPatrick W Serruys
Aug 28, 2019·Circulation. Cardiovascular Interventions·Dean J KereiakesIan T Meredith
Jan 17, 2020·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Geng WangYaling Han
May 16, 2020·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Walter J GomesRui M S Almeida
Jun 23, 2020·Circulation·Róisín Colleran, Robert A Byrne
Jun 27, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Shigeru SaitoTon Slagboom
Dec 21, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Soo-Hyun KimIn-Ho Chae
Apr 11, 2019·European Journal of Preventive Cardiology·George Cm SiontisLukas Hunziker
Jun 19, 2019·Future Cardiology·Ofer Kobo, Ariel Roguin
Aug 28, 2020·Current Opinion in Cardiology·Rosaly A BuitenClemens von Birgelen
Oct 9, 2020·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Laura S M KerkmeijerRobbert J de Winter
Jul 1, 2020·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Giulio G StefaniniAndreas Baumbach
Jan 14, 2021·Cardiovascular Intervention and Therapeutics·Shoichi KuramitsuTakeshi Kimura
Dec 29, 2020·JACC. Cardiovascular Interventions·Nevio TaglieriTullio Palmerini
Jan 11, 2020·JACC. Cardiovascular Interventions·Jeong Cheon ChoeUNKNOWN Korea Acute Myocardial Infarction Registry-National Institutes of Health Investigators
Jan 20, 2020·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Soeren MattkeDavid E Kandzari
Mar 16, 2021·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Per GrimfjärdStefan James
Mar 18, 2021·JACC. Cardiovascular Interventions·Thomas PilgrimJuan F Iglesias
Sep 10, 2020·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Ofer Kobo, Ariel Roguin
Apr 17, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Nader MankeriousAbdelhakim Allali
May 10, 2020·JACC. Cardiovascular Interventions·Raffaele Piccolo, Giovanni Esposito
May 16, 2019·Lancet·Lee-Jen WeiHuili Zhu
Jul 16, 2021·Circulation Journal : Official Journal of the Japanese Circulation Society·Eline H PloumenClemens von Birgelen
Jul 9, 2021·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Yasin HussainAlexandra Lansky
Aug 11, 2021·The Canadian Journal of Cardiology·Bradley H StraussGabby Elbaz-Greener

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Thomas PilgrimStephan Windecker
© 2022 Meta ULC. All rights reserved